BDKRB1 and neoplasm: The co-injection of i.v. NG29 with the albumin-binding dye Evans blue caused brain tumor-specific accumulation of the dye (Figure 6B), suggesting that i.v. administered NG29 homes to brain tumors by initially binding to B1R that are specifically expressed on tumor microvessels.